Earnings are out
AVXL · NASDAQ · Biotechnology

Anavex Life Sciences

Develops oral investigational therapies for neurodegenerative and neurodevelopmental diseases.

$2.99
After-hours close+0.00 (+0.14%)
At close$2.99(−4.63%)
DateEstimateReportedSurprise
Nov 2026−$0.11
Aug 2026−$0.08−$0.03+62.5%
Aug 2026−$0.08−$0.080.0%
Aug 2026−$0.08−$0.06+25.0%
Aug 2026−$0.08−$0.06+25.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2026
Aug 2026
Aug 2026
Aug 2026
Jul 2026
Jul 2026−$0.07
Jun 2026
Jun 2026
Jun 2026
Jun 2026
Jun 2026
May 2026
Feb 2026
Nov 2025
Aug 2025
May 2025
Feb 2025
Dec 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Aug 2021
May 2021
Feb 2021
Dec 2020
Aug 2020
May 2020
Feb 2020
Dec 2019
Aug 2019
May 2019
Feb 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 24, 2026−$0.11
Aug 28, 2026−$0.08−$0.03+62.5%
Aug 25, 2026−$0.08−$0.080.0%
Aug 24, 2026−$0.08−$0.06+25.0%
Aug 21, 2026−$0.08−$0.06+25.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 18, 2026
Aug 17, 2026
Aug 11, 2026
Aug 10, 2026
Jul 30, 2026
Jul 9, 2026−$0.07
Jun 30, 2026
Jun 23, 2026
Jun 16, 2026
Jun 9, 2026
Jun 2, 2026
May 29, 2026
Feb 9, 2026
Nov 25, 2025
Aug 12, 2025
May 13, 2025
Feb 12, 2025
Dec 23, 2024
Aug 6, 2024
May 9, 2024
Feb 7, 2024
Nov 27, 2023
Aug 8, 2023
May 9, 2023
Feb 7, 2023
Nov 28, 2022
Aug 9, 2022
May 10, 2022
Feb 9, 2022
Nov 24, 2021
Aug 12, 2021
May 13, 2021
Feb 11, 2021
Dec 28, 2020
Aug 6, 2020
May 7, 2020
Feb 6, 2020
Dec 16, 2019
Aug 7, 2019
May 8, 2019
Feb 7, 2019